Ariez B.V.

Dr. Joshua Sabari

Ariez Publishing

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 5:37

Dr. Sabari shares the results of a phase I study of amivantamab and discusses what these results means for patients with metastatic non-small cell lung cancer (NSCLC) harbouring EGFR exon 20 insertion mutations.